Investor Centre

0.01
UN
CH.
0.00
(0.00)
10:42PM 18/8 (NZST)
VOLUME
5290042
52 WEEK RANGE
0.0045 - 0.013
1 YR RETURN
-0
Key Information

MARKET CAPITALISATION

$12853600

Novel therapies for serious diseases

LCT is an Australasian biotechnology company improving the wellbeing of people with serious diseases by discovering, developing and commercialising novel treatments for debilitating conditions such as Parkinson’s disease, obesity and migraine.

Our product candidates leverage the potential of cells and their receptors to address serious conditions that have an unmet need for effective treatments.

We are listed on both the Australian Securities Exchange (ASX:LCT) and the international OTCQB (LVCLY). Share registry services are provided by Computershare.